Insider · CIK 0001438462

Hudson Frederick M.

Reports to the SEC for 4 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001438462

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-12	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,369 sh	$50.61	−$272K	60,413
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,475 sh	—	—	65,782
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−4,475 sh	—	—	0
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+4,977 sh	—	—	4,977
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,989 sh	—	—	2,989
2026-01-09	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$12.98	+$195K	61,307
2026-01-09	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.8K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.3K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,124 sh	—	—	0
2025-08-14	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,457 sh	$42.26	−$315K	46,307
2025-06-03	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+5,369 sh	—	—	53,764
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,369 sh	—	—	0
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,296 sh	—	—	7,296
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+4,475 sh	—	—	4,475
2025-01-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2025-01-22	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$9.13	+$183K	48,395
2024-11-08	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,722 sh	$36.28	−$316K	28,395
2024-06-11	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.8K sh	—	—	19,750
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,886 sh	—	—	37,117
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,886 sh	—	—	0
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,252 sh	—	—	8,252
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,369 sh	—	—	5,369
2023-11-15	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,457 sh	$9.24	+$68.9K	42,324
2023-11-15	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,882 sh	$28.50	−$111K	38,442
2023-11-15	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,211 sh	$28.50	−$149K	33,231
2023-11-15	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,457 sh	—	—	0
2023-06-06	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.3K sh	—	—	17,300
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,886 sh	—	—	3,886
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,293 sh	—	—	6,293
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,882 sh	—	—	0
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,882 sh	—	—	34,867
2023-01-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,722 sh	—	—	0
2023-01-10	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,722 sh	$7.90	+$68.9K	30,985
2022-06-14	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.3K sh	—	—	16,300
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,847 sh	—	—	6,847
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,882 sh	—	—	3,882
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,222 sh	—	—	22,263
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,222 sh	—	—	0
2021-06-08	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.3K sh	—	—	16,300
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,222 sh	—	—	4,222
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,365 sh	—	—	7,365
2020-07-13	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,750 sh	$2.56	+$22.4K	18,961
2020-07-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−920 sh	$24.44	−$22.5K	18,041
2020-07-13	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,750 sh	—	—	0
2020-06-09	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,124 sh	—	—	6,124
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+9,305 sh	—	—	9,305
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+5,211 sh	$23.99	+$125K	10,211

Recent filings

Accepted (ET)
Mar 164
Hudson Frederick M.0001438462-26-000006
SEC(opens sec.gov)
Feb 254
Hudson Frederick M.0001438462-26-000004
SEC(opens sec.gov)
Feb 204
Hudson Frederick M.0001438462-26-000002
SEC(opens sec.gov)
Jan 124
Hudson Frederick M.0001628280-26-001817
SEC(opens sec.gov)
Oct 74
Hudson Frederick M.0001193125-25-233534
SEC(opens sec.gov)
Aug 184
Hudson Frederick M.0001628280-25-040662
SEC(opens sec.gov)
Jun 54
Hudson Frederick M.0000950170-25-082434
SEC(opens sec.gov)
Feb 244
Hudson Frederick M.0001628280-25-007479
SEC(opens sec.gov)
Feb 214
Hudson Frederick M.0001628280-25-007191
SEC(opens sec.gov)
Jan 234
Hudson Frederick M.0001628280-25-002388
SEC(opens sec.gov)
Nov 124
Hudson Frederick M.0001628280-24-047152
SEC(opens sec.gov)

Companies

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850